DATE
Exact Sciences Advances Toward FDA Submission with Promising Blood-Based Colorectal Cancer Screening Test
Exact Sciences, Blood-Based Colorectal Cancer Screening, ESMO 2024, FDA Submission, Colorectal Cancer Detection, Advanced Precancerous Lesions
ESMO 2023: Merck’s Welireg Demonstrates Sustained PFS Benefit in Advanced Renal Cell Carcinoma, Despite Ongoing OS Concerns
Merck & Co., Welireg (belzutifan), ESMO 2023, Advanced Renal Cell Carcinoma (RCC), Progression-Free Survival (PFS), Overall Survival (OS), LITESPARK-005 trial
Biopharma Layoff Tracker 2024: Ongoing Industry Downsizing
Biopharma layoffs, 2024 layoffs, pharmaceutical industry downsizing, biotech job cuts, pharma restructuring
Biopharma Layoff Tracker 2024: Industry Continues to Downsize Amid Economic Uncertainty
Biopharma layoffs, 2024 layoffs, Pharmaceutical industry downsizing, Biotech industry trends, Economic uncertainty